Skip to main content

Advertisement

Log in

Reversed-polarity Treg cell TCRs provide a shock

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

Docking of T cell antigen receptors (TCRs) engaging complexes of peptide and major histocompatibility complex has shown the same diagonal orientation and polarity. A new study demonstrating that TCRs from regulatory T cells bind with reversed polarity challenges this dogma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: TCR-peptide interactions.

References

  1. Beringer, T. et al. Nat. Immunol. 16, 1153–1161 (2015).

    Article  CAS  Google Scholar 

  2. Attaf, M., Legut, M., Cole, D.K. & Sewell, A.K. Clin. Exp. Immunol. 181, 1–18 (2015).

    Article  CAS  Google Scholar 

  3. Rangarajan, S. & Mariuzza, R.A. Cell. Mol. Life Sci. 71, 3059–3068 (2014).

    Article  CAS  Google Scholar 

  4. Garcia, K.C. Trends Immunol. 33, 429–436 (2012).

    Article  CAS  Google Scholar 

  5. Tungatt, K. et al. J. Immunol. 194, 463–474 (2015).

    Article  CAS  Google Scholar 

  6. Cole, D.K. et al. J. Immunol. 178, 5727–5734 (2007).

    Article  CAS  Google Scholar 

  7. Gagliani, N. et al. Nat. Med. 19, 739–746 (2013).

    Article  CAS  Google Scholar 

  8. Tree, T.I. et al. Diabetes 59, 1451–1460 (2010).

    Article  CAS  Google Scholar 

  9. Arif, S. et al. Diabetes 63, 3835–3845 (2014).

    Article  CAS  Google Scholar 

  10. Arif, S. et al. J. Clin. Invest. 113, 451–463 (2004).

    Article  CAS  Google Scholar 

  11. Gibson, V.B. et al. Clin. Exp. Immunol. doi:10.1111/cei.12687 (22 July 2015).

  12. Thrower, S.L. et al. Clin. Exp. Immunol. 155, 156–165 (2009).

    Article  CAS  Google Scholar 

  13. Burton, B.R. et al. Nat. Commun. 5, 4741 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mark Peakman or Andrew K Sewell.

Ethics declarations

Competing interests

M.P. and King's College London have a license agreement with UCB Pharma to develop a peptide-based immunotherapy for type 1 diabetes.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peakman, M., Sewell, A. Reversed-polarity Treg cell TCRs provide a shock. Nat Immunol 16, 1105–1107 (2015). https://doi.org/10.1038/ni.3289

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3289

  • Springer Nature America, Inc.

Navigation